The Latest Breaking News from FDA

Experts say the DEA’s rescheduling of cannabis as a medication will be ‘a little bit incoherent’

The justices find that a president has immunity for ‘official acts’ but is not immune for ‘unofficial acts’ — and refer the matter back to a trial judge

At least 48 people in 24 states said they got sick after eating Diamond Shruumz-brand products

Eli Lilly says Kisunla demonstrated ‘meaningful results’ for people showing early symptoms of the disease

Eli Lilly won FDA approval for its Alzheimer's treatment, donanemab, on Tuesday. But Eli Lilly stock remained in the red.

U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease

The blend of growth potential and stability in mid-cap pharma stocks is driven by rising demand for innovative therapies, strong economic conditions, and technological advancements that boost the sector's growth trajectory. Therefore, considering strong mid-cap stocks like Amphastar Pharmaceuticals (AMPH), Catalyst Pharmaceuticals (CPRX), and ACADIA Pharmaceuticals (ACAD), expected to soar…

 The decision comes weeks after the FDA authorized the marketing of the first menthol-flavored vaping products.

The Supreme Court announced Tuesday it will decide disputes over online access to pornography in Texas and FDA approval of vapes.